KyDo Therapeutics

Dortmund, Germany

KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.

$5.3M raised

Sep 2025

Seed

Biopharma Biotechnology Medical

Top Investors

i&i Biotech Fund KHAN Technology Transfer Fund VORNvc TU capital

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about KyDo Therapeutics

How much funding has KyDo Therapeutics raised?

KyDo Therapeutics has raised $5.3M in total funding. The most recent round was Seed. The last funding was announced in September 2025.

Who are KyDo Therapeutics's investors?

KyDo Therapeutics's investors include i&i Biotech Fund, KHAN Technology Transfer Fund, VORNvc, TU capital.

Where is KyDo Therapeutics headquartered?

KyDo Therapeutics is headquartered in Dortmund, Germany.

What does KyDo Therapeutics do?

KyDo Therapeutics is a biotechnology company that develops novel covalent-allosteric small molecule inhibitors.

What stage is KyDo Therapeutics at?

KyDo Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 16, 2025.

MLA

"KyDo Therapeutics — Funding & Investors." VCBacked, September 16, 2025, https://www.vcbacked.co/company/kydo-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2025). KyDo Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/kydo-therapeutics

Wikipedia (cite web)

{{cite web |title=KyDo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/kydo-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 16, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.